OBJECT: The authors have shown that convection-enhanced delivery (CED) of gadoteridol-loaded liposomes (GDLs) into different regions of normal monkey brain results in predictable, widespread distribution of this tracking agent as detected by real-time MR imaging. They also have found that this tracking technique allows monitoring of the distribution of similar nanosized agents such as therapeutic liposomes and viral vectors. A limitation of this procedure is the unexpected leakage of liposomes out of targeted parenchyma or malignancies into sulci and ventricles. The aim of the present study was to evaluate the efficacy of CED after the onset of these types of leakage. METHODS: The authors documented this phenomenon in a study of 5 nonhuman primates and 7 canines, comprising 54 CED infusion sessions. Approximately 20% of these infusions resulted in leakage into cerebral ventricles or sulci. All of the infusions and leakage events were monitored with real-time MR imaging. The authors created volume-distributed versus volume-infused graphs for each infusion session. These graphs revealed the rate of distribution of GDL over the course of each infusion and allowed the authors to evaluate the progress of CED before and after leakage. RESULTS: The distribution of therapeutics within the target structure ceased to increase or resulted in significant attenuation after the onset of leakage. CONCLUSIONS: An analysis of the cases in this study revealed that leakage undermines the efficacy of CED. These findings reiterate the importance of real-time MR imaging visualization during CED to ensure an accurate, robust distribution of therapeutic agents.
OBJECT: The authors have shown that convection-enhanced delivery (CED) of gadoteridol-loaded liposomes (GDLs) into different regions of normal monkey brain results in predictable, widespread distribution of this tracking agent as detected by real-time MR imaging. They also have found that this tracking technique allows monitoring of the distribution of similar nanosized agents such as therapeutic liposomes and viral vectors. A limitation of this procedure is the unexpected leakage of liposomes out of targeted parenchyma or malignancies into sulci and ventricles. The aim of the present study was to evaluate the efficacy of CED after the onset of these types of leakage. METHODS: The authors documented this phenomenon in a study of 5 nonhuman primates and 7 canines, comprising 54 CED infusion sessions. Approximately 20% of these infusions resulted in leakage into cerebral ventricles or sulci. All of the infusions and leakage events were monitored with real-time MR imaging. The authors created volume-distributed versus volume-infused graphs for each infusion session. These graphs revealed the rate of distribution of GDL over the course of each infusion and allowed the authors to evaluate the progress of CED before and after leakage. RESULTS: The distribution of therapeutics within the target structure ceased to increase or resulted in significant attenuation after the onset of leakage. CONCLUSIONS: An analysis of the cases in this study revealed that leakage undermines the efficacy of CED. These findings reiterate the importance of real-time MR imaging visualization during CED to ensure an accurate, robust distribution of therapeutic agents.
Authors: Michal T Krauze; Tracy R Mcknight; Yoji Yamashita; John Bringas; Charles O Noble; Ryuta Saito; Karsten Geletneky; John Forsayeth; Mitchel S Berger; Pamela Jackson; John W Park; Krystof S Bankiewicz Journal: Brain Res Brain Res Protoc Date: 2005-09-21
Authors: K S Bankiewicz; J L Eberling; M Kohutnicka; W Jagust; P Pivirotto; J Bringas; J Cunningham; T F Budinger; J Harvey-White Journal: Exp Neurol Date: 2000-07 Impact factor: 5.330
Authors: Ryuta Saito; Michal T Krauze; John R Bringas; Charles Noble; Tracy R McKnight; Pamela Jackson; Michael F Wendland; Christoph Mamot; Daryl C Drummond; Dimitri B Kirpotin; Keelung Hong; Mitchel S Berger; John W Park; Krystof S Bankiewicz Journal: Exp Neurol Date: 2005-09-28 Impact factor: 5.330
Authors: John H Sampson; Raghu Raghavan; Martin L Brady; James M Provenzale; James E Herndon; David Croteau; Allan H Friedman; David A Reardon; R Edward Coleman; Terence Wong; Darell D Bigner; Ira Pastan; María Inmaculada Rodríguez-Ponce; Philipp Tanner; Raj Puri; Christoph Pedain Journal: Neuro Oncol Date: 2007-04-13 Impact factor: 12.300
Authors: Sandeep Kunwar; Michael D Prados; Susan M Chang; Mitchel S Berger; Frederick F Lang; Joseph M Piepmeier; John H Sampson; Zvi Ram; Philip H Gutin; Robert D Gibbons; Kenneth D Aldape; David J Croteau; Jeffrey W Sherman; Raj K Puri Journal: J Clin Oncol Date: 2007-03-01 Impact factor: 44.544
Authors: John H Sampson; Martin L Brady; Neil A Petry; David Croteau; Allan H Friedman; Henry S Friedman; Terence Wong; Darell D Bigner; Ira Pastan; Raj K Puri; Christoph Pedain Journal: Neurosurgery Date: 2007-02 Impact factor: 4.654
Authors: Piotr Hadaczek; Yoji Yamashita; Hanna Mirek; Laszlo Tamas; Martha C Bohn; Charles Noble; John W Park; Krystof Bankiewicz Journal: Mol Ther Date: 2006-05-02 Impact factor: 11.454
Authors: Neal Luther; Nai-Kong Cheung; Eleni P Souliopoulos; Ioannis Karampelas; Ioannis Karempelas; Daniel Bassiri; Mark A Edgar; Hong-Fen Guo; Ira Pastan; Philip H Gutin; Mark M Souweidane Journal: Mol Cancer Ther Date: 2010-04-06 Impact factor: 6.261
Authors: Wei Dai; Garrett W Astary; Aditya K Kasinadhuni; Paul R Carney; Thomas H Mareci; Malisa Sarntinoranont Journal: J Biomech Eng Date: 2016-05 Impact factor: 2.097
Authors: Massimo S Fiandaca; Vanja Varenika; Jamie Eberling; Tracy McKnight; John Bringas; Phillip Pivirotto; Janine Beyer; Piotr Hadaczek; William Bowers; John Park; Howard Federoff; John Forsayeth; Krystof S Bankiewicz Journal: Neuroimage Date: 2008-11-27 Impact factor: 6.556
Authors: Peter J Dickinson; Richard A LeCouteur; Robert J Higgins; John R Bringas; Richard F Larson; Yoji Yamashita; Michal T Krauze; John Forsayeth; Charles O Noble; Daryl C Drummond; Dmitri B Kirpotin; John W Park; Mitchel S Berger; Krystof S Bankiewicz Journal: Neuro Oncol Date: 2010-05-20 Impact factor: 12.300
Authors: Dali Yin; Francisco E Valles; Massimo S Fiandaca; John Bringas; Francisco Gimenez; Mitchel S Berger; John Forsayeth; Krystof S Bankiewicz Journal: Neuroimage Date: 2009-09-15 Impact factor: 6.556